Suppressive activity of a macrolide antibiotic, roxithromycin on co- stimulatory molecule expression on mouse splenocytes in vivo

Mediators of Inflammation

Volumn 9, Issue 1, 2000, Pages 39-43

  Kawazu, K ^a   Kurokawa, M ^a,c   Asano, K ^a   Mita, A ^b   Adachi, M ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY HOSPITAL   (Japan)

^c Kikuna Memorial Hospital   (Japan)

Author keywords

CD40; Dintrophenylated ovalbumin; Immunization; In vivo; Mouse; Roxithromycin; Suppression

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 4; OVALBUMIN; ROXITHROMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IMMUNOGLOBULIN PRODUCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL;

ANIMALIA;

EID: 0034045327     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350050024375     Document Type: Article

References (29)

1. 1. Itkin TH, Menzel ML. The use of antibiotic substances in the treatment of asthma. J Allergy 1970; 45: 146-162.
2. 2. Spector SL, Katz FH, Farr RS. Troleandomycin: effectiveness in steroid-dependent asthma and bronchitis. J Allergy Clin Immunol 1974; 54: 375-379.
3. 3. Miyatake H, Taki F, Taniguchi H, et al. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 1991; 99: 670-673.
4. 4. Miyachi Y, Yoshida A, Imamura S, Niwa Y. Effect of antibiotics on generation of reactive oxygen species. J Invest Dermatol 1986; 86: 449-453.
5. 5. Plewig G, Schopf E. Anti-inflammatory effects of antimocrobial agents: an in vivo study. J Invest Dermatol 1975; 65: 532-536.
6. 6. Konno S, Adachi M, Asano K, Okamoto K, Takahashi T. Anti-allergic activity of roxithromycin: inhibition of interleukin-5 production from mouse T lymphocytes. Life Sci 1993; 52: 25-30.
7. 7. Konno S, Adachi M, Asano K, et al. Influence of roxithromycin on cell-mediated immune responses. Life Sci 1992; 51: 107-112.
8. 8. Konno S, Adachi M, Asano K, Okamoto K, Takahashi T. Inhibition of human T-lymphocyte activation by macrolide antibiotic, roxithromycin. Life Sci 1992; 51: 231-236.
9. 9. Konno S, Asano K, Kurokawa M, et al. Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo. Int Arch Allergy Immunol 1991; 105: 308-316.
10. 10. Eyrand A, Descotes J, Lombard JY, Laschi-Loquerie A, Tachon P. Effects of erythromycin, josamycin and spiramycin on rat polymorphonuclear leukocyte chemotaxis. Chemotherapy 1986; 32: 379-382.
11. 11. Forsgren A, Schmeling D. Effect of antibiotics on chemotaxis of human leukocytes. Antimicrob Agents Chemother 1977; 11: 580-584.
12. 12. Lenschow DJ, Walnus TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233-258.
13. 13. Robinson DS. T cell costimulation: a potential therapeutic target in asthma? Clinical Exp Allergy 1998; 28: 788-790.
14. 14. Marone G. Asthma: recent advances. Immunol Today 1998; 19: 5-9.
15. 15. Worm M, Henz BM. Molecular regulation of human IgE synthesis. J Mol Med 1997; 75: 440-447.
16. 16. Hofer MF, Jirapongsananuruk O, Trumble A, Leung DYM. Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J Allergy Clin Immunol 1998; 101: 96-102.
17. 17. Jirapongsananuruk O, Hofer MF, Trumble AE, Norris DA, Leung DY. Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis. J Immunol 1998; 160: 4622-4627.
18. 18. Mark DA, Donovan CE, De Sanctis GT. Both CD80 and CD86 co-stimulatory molecules regulate allergic pulmonary inflammation. Int Immunol 1998; 10: 1647-1655.
19. 19. Ishizaka K, Iwata M, Carini C, Katamura K, Takeuchi T. Antigen-specific factors in IgE regulation. In: Sorg C, ed. Cytokines Regulating the Allergic Response. Basel: Karger, 1989: 1-18
20. 20. Jabara HH, Ahern D, Vercelli D, Geha RS. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J Exp Med 1991; 147: 1557-1560.
21. 21. Kimata H. Differential effects on gangliosides on human IgE and IgG4 production. Eur J Immunol 1995; 25: 302-305.
22. 22. Schatz DG, Oettinger MA, Schissel MS. V(D)J recombination: molecular biology and regulation. Ann Rev Immunol 1992; 10: 359-383.
23. 23. Hamid Q. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin Invest 1991; 87: 1541-1546.
24. 24. Del Prete GF, 1993. Allergen exposure induces the activation of allergen-specific Th2 cells in airway mucosa of patients allergic respiratory disorders. Eur J Immunol 1993; 23: 1445-1449.
25. 25. Ying S. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997; 158: 3539-3544.
26. 26. Tsuyuki S, Tsuyuki J, Einsle K, Kopf M, Coyle AJ. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med 1997; 185: 1671-1679.
27. 27. Van Neerven RJJ, Van De Pol MM, Van Der Zee JS, et al. Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression. Clin Exp Allergy 1998; 28: 808-816.
28. 28. Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J Immunol 1990; 144: 251-258.
29. 29. Screiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK-506. Immnol Today 1992; 13: 136-142.